Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Genome-Wide Profiling of DNA Copy Number Variation in CLL Cases Lacking 17p- (TP53) or 11q- (ATM) Abnormalities Selected from the CLL4 Study

Sarah L Hockley, PhD, David Gonzalez, PhD, Vasantha Brito-Babapulle, PhD, Monica Else, MA, MSc, Paola E Leone, Brian A Walker, Estella Matutes, MD, PhD, Claire E Dearden, MD, Daniel Catovsky, MD, DSc(Med), Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 3140.

https://doi.org/10.1182/blood.V112.11.3140.3140

Published: 2008

Journal Articles

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

David Gonzalez, PhD, Pilar Martinez, MD, PhD, Rachel Wade, Sarah Lorna Hockley, PhD, Vasantha Brito-Babapulle, PhD, David Graham Oscier, MD, Estella Matutes, MD, PhD, Claire E Dearden, Sue Richards, Daniel Catovsky, MD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 784.

https://doi.org/10.1182/blood.V112.11.784.784

Published: 2008

Journal Articles

Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion.

Hannah C. Rudenko, MSc, Vasantha Brito-Babapulle, PhD, David Gonzalez, PhD, Pilar Martinez, MD, Paola E. Leone, PhD, Chris Jones, PhD, Tim Dexter, PhD, Kerry Fenwick, MSc, Alan Mackay, BSc, Alan Ashworth, PhD, Estella Matutes, MD, Daniel Catovsky, MD, Claire Dearden, MD, Gareth J. Morgan, MD,PhD

Blood (2006) 108 (11): 2091.

https://doi.org/10.1182/blood.V108.11.2091.2091

Published: 2006

Journal Articles

Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion.

Vasantha Brito-Babapulle, PhD, Hannah Rudenko, MSc, Claire Dearden, MD, Kerry Fenwick, BSc, Alan Mckay, BSc, Alan Ashworth, PhD, Estella Matutes, MD, Daniel Catovsky, MD, Gareth Morgan, MD

Blood (2005) 106 (11): 2110.

https://doi.org/10.1182/blood.V106.11.2110.2110

Published: 2005

Journal Articles

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

Ilaria Del Giudice, MD, Nnenna Osuji, MRCPath, Tim Dexter, PhD, Estella Matutes, FRCPath, Vasantha Brito-Babapulle, PhD, Nilima Parry-Jones, MD, Daniel Catovsky, FRCPath

Blood (2005) 106 (11): 4372.

https://doi.org/10.1182/blood.V106.11.4372.4372

Published: 2005

Journal Articles

Gene Expression Reveals Two Distinct Biological Groups within T-Cell Prolymphocytic Leukaemia.

Nnenna Osuji, MRCPath, Ilaria Del Giudice, MD, Tim Dexter, PhD, Estella Matutes, FRCPath, Vasantha Brito-Babapulle, PhD, David Gonzalez, PhD, Brian A. Walker, PhD, Daniel Catovsky, FRCPath

Blood (2005) 106 (11): 4366.

https://doi.org/10.1182/blood.V106.11.4366.4366

Published: 2005

Journal Articles

ZAP-70 Expression in Chronic Lymphocytic Leukemia: Correlation with Clinical and Biological Features.

Ilaria Del Giudice, Nnenna Osuji, Estella Matutes, Alison Morilla, Ricardo Morilla, Anna Burford, Sonia Maravelaki, Kwasi Owusu-Ankomah, John Swansbury, Vasantha Brito-Babapulle, Daniel Catovsky

Blood (2004) 104 (11): 1915.

https://doi.org/10.1182/blood.V104.11.1915.1915

Published: 2004

Journal Articles

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

Ilaria Del Giudice, Zadie Davis, Nnenna Osuji, Nilima Parry-Jones, Estella Matutes, Vasantha Brito-Babapulle, Andrew Wotherspoon, David Oscier, Daniel Catovsky

Blood (2004) 104 (11): 2004.

https://doi.org/10.1182/blood.V104.11.2004.2004

Published: 2004

Journal Articles

Intra-Lineage Phenotypic Switch in T-Cell Prolymphocytic Leukemia.

Nnenna Osuji, Ilaria Del Giudice, Estella Matutes, Vasantha Brito-Babapulle, Alison Morilla, Kwasi Owuso-Ankomah, Ricardo Morilla, Daniel Catovsky

Blood (2004) 104 (11): 2005.

https://doi.org/10.1182/blood.V104.11.2005.2005

Published: 2004

Journal Articles

Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.

Daniel Catovsky, MD, DSC, Estella Matutes, MD, PhD, Alison Morilla, BSc, Anna Burford, BSc, Vasantha Brito-Babapulle, PhD, Ilaria Del-Giudice, MD, Jennifer Orchard, MD, David G. Oscier, MD, Jim Halsey, PhD, Sue Richards, PhD

Blood (2004) 104 (11): 957.

https://doi.org/10.1182/blood.V104.11.957.957

Published: 2004

Journal Articles

Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial.

Daniel Catovsky, MD, DSc, Sue Richards, PhD, Estella Matutes, Anna Burford, BSc, Vasantha Brito-Babapulle, PhD, Claire Dearden, MD, Philip Morris, PhD, Andrew Pettitt, PhD, MRCPath

Blood (2004) 104 (11): 13.

https://doi.org/10.1182/blood.V104.11.13.13

Published: 2004

Journal Articles

The WHO classification of mature T-cell leukemias

Daniel Catovsky, Estella Matutes, Claire Dearden, Nnenna Osuji, Vasantha Brito-Babapulle

Blood (2004) 104 (9): 2989–2990.

https://doi.org/10.1182/blood-2004-06-2065

Published: 2004

Journal Articles

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Claire E. Dearden, Estella Matutes, Bruno Cazin, Geir E. Tjønnfjord, Antonio Parreira, Benet Nomdedeu, Pietro Leoni, Fiona J. Clark, Deepti Radia, Saad M. B. Rassam, Tony Roques, Nicolas Ketterer, Vasantha Brito-Babapulle, Martin J. S. Dyer, Daniel Catovsky

Blood (2001) 98 (6): 1721–1726.

https://doi.org/10.1182/blood.V98.6.1721

Published: 2001

NARROW

Genome-Wide Profiling of DNA Copy Number Variation in CLL Cases Lacking 17p- (TP53) or 11q- (ATM) Abnormalities Selected from the CLL4 Study

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion.

Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion.

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

Gene Expression Reveals Two Distinct Biological Groups within T-Cell Prolymphocytic Leukaemia.

ZAP-70 Expression in Chronic Lymphocytic Leukemia: Correlation with Clinical and Biological Features.

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

Intra-Lineage Phenotypic Switch in T-Cell Prolymphocytic Leukemia.

Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.

Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial.

The WHO classification of mature T-cell leukemias

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only